Why the study?
The no-reflow phenomenon can obstruct coronary flow during primary PCI for ACS, prompting evaluation and comparison of predictive parameters.
Do hematological and biochemical parameters predict the no-reflow phenomenon in patients with acute coronary syndromes undergoing primary percutaneous coronary intervention?
Do hematological and biochemical parameters predict the no-reflow phenomenon in patients with acute coronary syndromes undergoing primary percutaneous coronary intervention?
Routine hematological and biochemical parameters, particularly white blood cell count, can independently predict the risk of no-reflow phenomenon in ACS patients undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
Routine labs may aid no-reflow risk stratification in primary PCI; hypothesis-generating and requires prospective validation before clinical use.
Acute coronary syndromes (ACS) are one of the most common causes of morbidity and mortality worldwide. Primary percutaneous coronary intervention (pPCI) is the main treatment strategy to restore myocardial perfusion. However, the no-reflow phenomenon (NRP) may block coronary flow. The present study focused on assessing and contrasting predictive parameters for NRP in ACS patients. Our research is a retrospective analysis. We assessed the parameters significantly associated with NRP using Cox regression and Receiver operating characteristic (ROC) Curve analysis. The study included 5122 patients who met the criteria. The average age of the patients was 63.9 + 13.2, and 74.4% were male. It was observed that NRP developed in 1.8% of all patients. Age, hemoglobin (Hb), white blood cell (WBC), glucose and low density lipoprotein cholesterol (LDL-C) were determined to be independent predictors of NRP. The power of these parameters to predict NRP was similar, and WBC was the most predictive (Area Under Curve (AUC): 0.605 95% CI: 0.539-0.671, P = .001). We believe that the use of these simple, practical, and routinely used hematological and biochemical parameters will help us predict the risk of developing NRP before pPCI. This information should improve management.
No takes yet. Share an insight, caveat, or question.
Aydemir et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: